NEWTOWN, Pa.----CollaGenex Pharmaceuticals, Inc. today announced that a new report in the May 2007 issue of the Journal of the American Academy of Dermatology evaluating two randomized phase III clinical trials, demonstrated the efficacy and safety of anti-inflammatory dose doxycycline for the treatment of rosacea.
From: biz.yahoo.com
Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory Dose Doxycycline for the Treatment of Rosacea
Posted by Ruslan Abuzant at 7:32 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment